COR - Cencora, Inc.
NEXT EARNINGS:
May 6, 2026
EPS Est: $4.81
|
Rev Est: $81.4B
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$410.50
DETAILS
HIGH:
$440.00
LOW:
$340.00
MEDIAN:
$417.50
CONSENSUS:
$410.50
UPSIDE:
12.66%
Market Cap:
70.88B
Volume:
595,562
Avg Volume:
1,360,855
52 Week Range:
241.48-377.54
Sector:
Healthcare
Industry:
Medical - Distribution
Beta:
0.69
Last Dividend:
$2.30
Exchange:
NYSE
Country:
US
Employees:
47,000
IPO Date:
1995-04-04
EPS (TTM):
8.02
P/E Ratio:
38.98
Revenue (TTM):
321.33B
Total Assets:
76.59B
Total Debt:
10.75B
Cash & Equiv:
4.39B
Rev Growth (5Y):
11.1%
EPS Growth (5Y):
2.0%
FCF Growth (5Y):
11.8%
ROCE:
14.3%
Debt/Equity:
7.13
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2026-02-04 | $4.08 | $4.05 | +0.7% | $85.9B | $86.1B | -0.1% |
| 2025-11-05 | $3.84 | $3.79 | +1.3% | $83.7B | $83.5B | +0.3% |
| 2025-08-06 | $4.00 | $3.85 | +3.9% | $80.7B | $80.1B | +0.7% |
| 2025-05-07 | $4.42 | $4.11 | +7.5% | $75.5B | $75.7B | -0.3% |
| 2025-02-05 | $3.73 | $3.50 | +6.6% | $81.5B | $78.3B | +4.1% |
| 2024-11-06 | $3.34 | $3.23 | +3.4% | $79.1B | $77.6B | +1.8% |
| 2024-01-30 | $2.98 | — | — | $72.3B | — | — |
| 2023-11-02 | $1.72 | $2.79 | -38.4% | $68.9B | $66.1B | +4.3% |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 321.33B | 293.96B | 262.17B | 238.59B | 213.99B | 189.89B | 179.59B | 167.94B | 153.14B | 146.85B | 135.96B | 119.57B |
| Net Income | 1.55B | 1.51B | 1.75B | 1.70B | 1.54B | (3.40B) | 855.37M | 1.66B | 414.48M | 1.43B | (134.89M) | 276.48M |
| EPS | 8.02 | 7.60 | 8.53 | 8.15 | 7.48 | -16.60 | 4.07 | 7.53 | 1.90 | 6.73 | -0.62 | 1.22 |
| Total Assets | 76.59B | 67.10B | 62.56B | 56.56B | 57.34B | 43.95B | 39.17B | 37.67B | 35.32B | 33.59B | 27.74B | 21.53B |
| Total Debt | 10.75B | 4.39B | 4.79B | 5.70B | 6.68B | 4.12B | 4.17B | 4.31B | 3.43B | 3.59B | 3.49B | 2.00B |
| Cash & Equivalents | 4.39B | 3.13B | 2.59B | 3.39B | 2.55B | 4.60B | 3.37B | 2.49B | 2.42B | 2.74B | 2.17B | 1.81B |
| Operating Cash Flow | 3.88B | 3.48B | 1.30B | 2.70B | 2.67B | 2.21B | 2.34B | 1.41B | 1.49B | 3.18B | 3.92B | 1.46B |
| Free Cash Flow | 3.21B | 3.00B | 845.86M | 2.21B | 2.23B | 1.84B | 2.03B | 1.07B | 1.02B | 2.71B | 3.69B | 1.20B |
| FCF per Share | 16.55 | 15.10 | 4.13 | 10.59 | 10.82 | 8.97 | 9.68 | 4.93 | 4.68 | 12.79 | 16.94 | 5.27 |
| Book Value | 1.51B | 645.94M | 522.00M | (289.78M) | 223.35M | (839.64M) | 2.99B | 2.93B | 2.11B | 2.13B | 633.52M | 1.96B |
| Cash & ST Investments | 4.39B | 3.13B | 2.59B | 3.39B | 2.55B | 4.60B | 3.37B | 2.49B | 2.42B | 2.74B | 2.17B | 1.81B |
| ROC Equity | 1.03 | 2.34 | 3.34 | N/A | 6.89 | N/A | 0.29 | 0.57 | 0.20 | 0.67 | -0.21 | 0.14 |